ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 992,87
0,18%
Dow Jones
38 686,32
1,51%
DAX
18 497,94
-0,09%
Brent Oil
81,295
0,00%
Bitcoin
67 650,19
0,25%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Cellular Biomedicine Group Inc (CBMG)

  7. Cellular Biomedicine Group Inc (CBMG) Actualités

CBMG

Cellular Biomedicine (CBMG)

Cellular Biomedicine Group Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:CBMG
DateHeureSourceTitreSymboleSociété
03/03/202120h40Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:CBMGCellular Biomedicine Group Inc
26/02/202112h14Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:CBMGCellular Biomedicine Group Inc
22/02/202112h02Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:CBMGCellular Biomedicine Group Inc
19/02/202122h11Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...NASDAQ:CBMGCellular Biomedicine Group Inc
19/02/202121h14Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CBMGCellular Biomedicine Group Inc
19/02/202121h11Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:CBMGCellular Biomedicine Group Inc
19/02/202121h10Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:CBMGCellular Biomedicine Group Inc
19/02/202121h07Edgar (US Regulatory)Amended Statement of Ownership: Private Transaction (sc 13e3/a)NASDAQ:CBMGCellular Biomedicine Group Inc
19/02/202121h05Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CBMGCellular Biomedicine Group Inc
19/02/202120h55PR Newswire (US)Cellular Biomedicine Group, Inc. Announces Completion of MergerNASDAQ:CBMGCellular Biomedicine Group Inc
08/02/202122h19PR Newswire (US)Cellular Biomedicine Group, Inc. Stockholders Approve MergerNASDAQ:CBMGCellular Biomedicine Group Inc
01/02/202120h50Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:CBMGCellular Biomedicine Group Inc
28/01/202122h30PR Newswire (US)Leading Proxy Advisory Firms Glass Lewis and ISS Recommend Cellular Biomedicine Group Stockholders Vote FOR Proposed MergerNASDAQ:CBMGCellular Biomedicine Group Inc
26/01/202123h21Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:CBMGCellular Biomedicine Group Inc
29/12/202022h11Edgar (US Regulatory)Proxy Statement - Merger or Acquistion (definitive) (defm14a)NASDAQ:CBMGCellular Biomedicine Group Inc
08/12/202012h42Edgar (US Regulatory)Proxy Soliciting Materials (revised) (prer14a)NASDAQ:CBMGCellular Biomedicine Group Inc
04/12/202013h35PR Newswire (US)Cellular Biomedicine Group Announces Data to be Presented at 2020 ASH Annual MeetingNASDAQ:CBMGCellular Biomedicine Group Inc
09/11/202023h24PR Newswire (US)Cellular Biomedicine Group Reports Q3 2020 Financial Results and Business HighlightsNASDAQ:CBMGCellular Biomedicine Group Inc
09/11/202022h26Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CBMGCellular Biomedicine Group Inc
26/08/202015h00PR Newswire (US)Cellular Biomedicine Group to Present at Chinese Biopharmaceutical Association-USA Annual ConferenceNASDAQ:CBMGCellular Biomedicine Group Inc
14/08/202022h34Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:CBMGCellular Biomedicine Group Inc
14/08/202022h33Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:CBMGCellular Biomedicine Group Inc
13/08/202021h25Business WireALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Cellular Biomedicine Group, Inc.NASDAQ:CBMGCellular Biomedicine Group Inc
12/08/202022h30PR Newswire (US)Cellular Biomedicine Group (CBMG) Reports Q2, H1 2020 Financial Results and Business HighlightsNASDAQ:CBMGCellular Biomedicine Group Inc
12/08/202012h30PR Newswire (US)Cellular Biomedicine Group (CBMG) Enters Into Definitive Merger Agreement; Transaction Would Result In Company Going PrivateNASDAQ:CBMGCellular Biomedicine Group Inc
10/08/202022h17Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)NASDAQ:CBMGCellular Biomedicine Group Inc
13/07/202013h29PR Newswire (US)Cellular Biomedicine Group (CBMG) Hosts R&D Showcase and Provides Updates to Clinical ProgramsNASDAQ:CBMGCellular Biomedicine Group Inc
30/06/202022h15PR Newswire (US)Cellular Biomedicine Group (CBMG) to Host Investor R&D Showcase Highlighting Updates to Clinical ProgramsNASDAQ:CBMGCellular Biomedicine Group Inc
29/06/202014h55PR Newswire (US)Cellular Biomedicine Group (CBMG) Announces Results of 2020 Annual Meeting of StockholdersNASDAQ:CBMGCellular Biomedicine Group Inc
22/06/202015h00PR Newswire (US)Cellular Biomedicine Group (CBMG) Presents Poster of TCRs Targeting AFP-Positive Liver Cancer at AACR Annual MeetingNASDAQ:CBMGCellular Biomedicine Group Inc
 Showing the most relevant articles for your search:NASDAQ:CBMG

Dernières Valeurs Consultées

EU
GILS
Lyxor Core UK Government...
TSXV
CYG
CYGAM Energy Inc.
EU
COFA
Coface
USOTC
SCGY
Scientific Energy (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés